glutathione transferase inhibitors The role of glutathione-S-transferase in anti-cancer drug resistance In vitro and in silico

The surface modification of the liposome with ligands (antibodies or peptides) ensures targeted delivery to dopaminergic neurons, which could improve their targeting capabilities and efficacy and reduce side effects

Further evidence to support mechanistic role of H1 and muscarinic M3 receptors in AA associated metabolic effects include association of genetic variants of these receptors (two single-nucleotide polymorphisms in HRH1 and CHRM3 receptor genes) with BMI and glycated hemoglobin (HbA1c) concentrations in patients treated with antipsychotic drugs (Vehof et al., 2011)

Shi ZZ, Habib GM, Rhead WJ, Gahl WA, He X, Sazer S, Lieberman MW: Mutations in the glutathione synthetase gene cause 5-oxoprolinuria

[DOI] [PubMed] [Google Scholar] 141.Aguiar A.F.L., Campos R.M.P., Isaac A.R., Paes-Colli Y., Carvalho V.M., Sampaio L.S., de Melo Reis R.A